Literature DB >> 36043428

Characterization of POR haplotype distribution in African populations and comparison with other global populations.

Ross P Booyse1, David Twesigomwe1,2, Scott Hazelhurst2,3.   

Abstract

Background & aim: POR is an enzyme that mediates electron transfer to enable the drug-metabolizing activity of CYP450 proteins. However, POR has been understudied in pharmacogenomics despite this vital role. This study aimed to characterize the genetic variation in POR across African populations and to compare the star allele (haplotype) distribution with that in other global populations. Materials & methods: POR star alleles were called from whole-genome sequencing data using the StellarPGx pipeline.
Results: In addition to the common POR*1 and *28 (defined by rs1057868), five novel rare haplotypes were computationally inferred. No significant frequency differences were observed among the majority of African populations. However, POR*28 was observed at a higher frequency in individuals of non-African ancestry.
Conclusion: This study highlights the distribution of POR alleles in Africa and across global populations with a view toward informing future precision medicine implementation.

Entities:  

Keywords:  African populations; POR; StellarPGx; diplotypes; haplotypes; pharmacogenomics; star alleles

Mesh:

Year:  2022        PMID: 36043428      PMCID: PMC9531186          DOI: 10.2217/pgs-2022-0082

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.638


  37 in total

1.  Consequences of POR mutations and polymorphisms.

Authors:  Walter L Miller; Vishal Agrawal; Duanpen Sandee; Meng Kian Tee; Ningwu Huang; Ji Ha Choi; Kari Morrissey; Kathleen M Giacomini
Journal:  Mol Cell Endocrinol       Date:  2010-11-09       Impact factor: 4.102

2.  The P450 oxidoreductase *28 SNP is associated with low initial tacrolimus exposure and increased dose requirements in CYP3A5-expressing renal recipients.

Authors:  Hylke de Jonge; Christoph Metalidis; Maarten Naesens; Diether Lambrechts; Dirk R J Kuypers
Journal:  Pharmacogenomics       Date:  2011-07-19       Impact factor: 2.533

3.  Graphtyper enables population-scale genotyping using pangenome graphs.

Authors:  Hannes P Eggertsson; Hakon Jonsson; Snaedis Kristmundsdottir; Eirikur Hjartarson; Birte Kehr; Gisli Masson; Florian Zink; Kristjan E Hjorleifsson; Aslaug Jonasdottir; Adalbjorg Jonasdottir; Ingileif Jonsdottir; Daniel F Gudbjartsson; Pall Melsted; Kari Stefansson; Bjarni V Halldorsson
Journal:  Nat Genet       Date:  2017-09-25       Impact factor: 38.330

4.  Predicting functional effect of human missense mutations using PolyPhen-2.

Authors:  Ivan Adzhubei; Daniel M Jordan; Shamil R Sunyaev
Journal:  Curr Protoc Hum Genet       Date:  2013-01

5.  NADPH-cytochrome P450 oxidoreductase: roles in physiology, pharmacology, and toxicology.

Authors:  David S Riddick; Xinxin Ding; C Roland Wolf; Todd D Porter; Amit V Pandey; Qing-Yu Zhang; Jun Gu; Robert D Finn; Sebastien Ronseaux; Lesley A McLaughlin; Colin J Henderson; Ling Zou; Christa E Flück
Journal:  Drug Metab Dispos       Date:  2012-10-19       Impact factor: 3.922

6.  A Lack of Significant Effect of POR*28 Allelic Variant on Tacrolimus Exposure in Kidney Transplant Recipients.

Authors:  Anne-Sophie Jannot; Xavier Vuillemin; Isabelle Etienne; Mathias Buchler; Bruno Hurault de Ligny; Gabriel Choukroun; Charlotte Colosio; Antoine Thierry; Cécile Vigneau; Bruno Moulin; Jean-Philippe Rerolle; Anne-Elizabeth Heng; Jean-Francois Subra; Christophe Legendre; Philippe Beaune; Marie Anne Loriot; Eric Thervet; Nicolas Pallet
Journal:  Ther Drug Monit       Date:  2016-04       Impact factor: 3.681

7.  Integrative genomics viewer.

Authors:  James T Robinson; Helga Thorvaldsdóttir; Wendy Winckler; Mitchell Guttman; Eric S Lander; Gad Getz; Jill P Mesirov
Journal:  Nat Biotechnol       Date:  2011-01       Impact factor: 54.908

8.  African Genetic Diversity: Implications for Cytochrome P450-mediated Drug Metabolism and Drug Development.

Authors:  Iris Rajman; Laura Knapp; Thomas Morgan; Collen Masimirembwa
Journal:  EBioMedicine       Date:  2017-02-20       Impact factor: 8.143

9.  Identifying Mendelian disease genes with the variant effect scoring tool.

Authors:  Hannah Carter; Christopher Douville; Peter D Stenson; David N Cooper; Rachel Karchin
Journal:  BMC Genomics       Date:  2013-05-28       Impact factor: 3.969

10.  High-depth African genomes inform human migration and health.

Authors:  Ananyo Choudhury; Shaun Aron; Laura R Botigué; Dhriti Sengupta; Gerrit Botha; Taoufik Bensellak; Gordon Wells; Judit Kumuthini; Daniel Shriner; Yasmina J Fakim; Anisah W Ghoorah; Eileen Dareng; Trust Odia; Oluwadamilare Falola; Ezekiel Adebiyi; Scott Hazelhurst; Gaston Mazandu; Oscar A Nyangiri; Mamana Mbiyavanga; Alia Benkahla; Samar K Kassim; Nicola Mulder; Sally N Adebamowo; Emile R Chimusa; Donna Muzny; Ginger Metcalf; Richard A Gibbs; Charles Rotimi; Michèle Ramsay; Adebowale A Adeyemo; Zané Lombard; Neil A Hanchard
Journal:  Nature       Date:  2020-10-28       Impact factor: 69.504

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.